These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7995617)

  • 1. Subcutaneous growth hormone administration in growth-hormone-deficient children. Continuous plus pulsatile overnight versus single daily injection: effects on growth rate velocity.
    Cavallo L; De Luca F; Bernasconi S; Russo R; Zecchino C; Arrigo T
    Horm Res; 1994; 42(3):86-9. PubMed ID: 7995617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children.
    Tauber M; De Bouet Du Portal H; Sallerin-Caute B; Rochiccioli P; Bastide R
    J Clin Endocrinol Metab; 1993 May; 76(5):1135-9. PubMed ID: 8496303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults.
    Laursen T; Gravholt CH; Heickendorff L; Drustrup J; Kappelgaard AM; Jørgensen JO; Christiansen JS
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1222-8. PubMed ID: 11238512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different growth hormone administration frequencies on growth in growth hormone-deficient patients.
    Cavallo L; De Luca F; Bernasconi S; Arrigo T; Gurrado R; Zecchino C
    Horm Res; 1998; 49 Suppl 2():73-7. PubMed ID: 9730676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once versus twice daily injections of growth hormone in children with idiopathic short stature.
    Phillip M; Hershkovitz E; Belotserkovsky O; Leiberman E; Limoni Y; Zadik Z
    Acta Paediatr; 1998 May; 87(5):518-20. PubMed ID: 9641732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.
    Thorner M; Rochiccioli P; Colle M; Lanes R; Grunt J; Galazka A; Landy H; Eengrand P; Shah S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1189-96. PubMed ID: 8772599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of growth rate in growth hormone-deficient children treated with human growth hormone-releasing hormone.
    Thorner MO; Rogol AD; Blizzard RM; Klingensmith GJ; Najjar J; Misra R; Burr I; Chao G; Martha P; Mcdonald J
    Pediatr Res; 1988 Aug; 24(2):145-51. PubMed ID: 3141891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose growth hormone treatment of short children born small for gestational age.
    de Zegher F; Maes M; Gargosky SE; Heinrichs C; Du Caju MV; Thiry G; De Schepper J; Craen M; Breysem L; Löfström A; Jönsson P; Bourguignon JP; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1996 May; 81(5):1887-92. PubMed ID: 8626853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R; Jakubowicz S
    J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone dose-dependent pubertal growth: a randomized trial in short children with low growth hormone secretion.
    Albertsson-Wikland K; Kriström B; Lundberg E; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Ritzén M; Tuvemo T; Westgren U; Westphal O; Aman J
    Horm Res Paediatr; 2014; 82(3):158-70. PubMed ID: 25170833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous growth hormone-releasing hormone therapy in growth hormone-deficient children: first year of therapy.
    Duck SC; Schwarz HP; Costin G; Rapaport R; Arslanian S; Hayek A; Connors M; Jaramillo J
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1115-20. PubMed ID: 1400880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of subcutaneous and intramuscular administration of human growth hormone in the therapy of growth hormone deficiency.
    Russo L; Moore WV
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1003-6. PubMed ID: 6889608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.